Seven Eight Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,669
Closed -$927K 693
2024
Q2
$927K Sell
5,669
-4,780
-46% -$681K 0.1% 380
2024
Q1
$1.59M Buy
+10,449
New +$1.74M 0.17% 186
2022
Q3
Sell
-883
Closed -$482K 470
2022
Q2
$482K Buy
+883
New +$447K 0.19% 174

Other funds holding AGL

Seven Eight Capital's AGL Position: Q3 2024 in Review

Seven Eight Capital sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 5,669 shares — an estimated $927K sold.

Seven Eight Capital first reported a position in AGL in Q2 2022 and held it in 3 quarters. The position peaked at $1.59M in Q1 2024. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Seven Eight Capital reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Seven Eight Capital sold 5,669 Agilon Health shares in Q3 2024, an estimated $927K.
  • Seven Eight Capital first reported a position in Agilon Health in Q2 2022 and held it in 3 quarters.
  • Seven Eight Capital's Agilon Health position peaked at $1.59M in Q1 2024.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.